Your browser doesn't support javascript.
loading
Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome.
Jyonouchi, Soma; Gwafila, Brenda; Gwalani, Lavesh A; Ahmad, Maria; Moertel, Chistopher; Holbert, Cecil; Kim, Ji Young; Kobrinsky, Nathan; Roy-Ghanta, Sumita; Orange, Jordan S.
Afiliação
  • Jyonouchi S; Division of Allergy and Immunology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, United States. Electronic address: Jyonouchi@email.chop.edu.
  • Gwafila B; The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Gwalani LA; Division of Immunology Allergy and Rheumatology, Departments of Pediatrics, Pathology and Immunology, Baylor College of Medicine, United States; Center for Human Immunobiology, Texas Children's Hospital, United States.
  • Ahmad M; Phoenix Children's Hospital, Phoenix, AZ, United States.
  • Moertel C; The University of Minnesota Masonic Children's Hospital, Minneapolis, MN, United States.
  • Holbert C; Myers Clinic, Philippi, WV, United States.
  • Kim JY; The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Kobrinsky N; Roger Maris Cancer Center, Sanford Health, Fargo, ND, United States.
  • Roy-Ghanta S; Division of Allergy and Immunology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Orange JS; Division of Immunology Allergy and Rheumatology, Departments of Pediatrics, Pathology and Immunology, Baylor College of Medicine, United States; Center for Human Immunobiology, Texas Children's Hospital, United States.
Clin Immunol ; 179: 47-53, 2017 06.
Article em En | MEDLINE | ID: mdl-28232030
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Wiskott-Aldrich / Adjuvantes Imunológicos / Interleucina-2 Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Wiskott-Aldrich / Adjuvantes Imunológicos / Interleucina-2 Idioma: En Ano de publicação: 2017 Tipo de documento: Article